SCHEMBL6209007

SCHEMBL6209007

CCn1ccnc1/C=C/c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 6/20 0.48
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
GLA P06280 5/20 0.48
GAA P10253 5/20 0.48
HPGD P15428 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
MAPT P10636 4/20 0.48
RELA Q04206 2/20 0.48
PKM P14618 2/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
MAPK1 P28482 1/20 0.46
L3MBTL1 Q9Y468 5/20 0.42
TP53 P04637 4/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6209010 1.00 KDM4E (0.48) KDM4EALDH1A1NPC1RAB9AGLA
SCHEMBL5459711 0.79 TOP2A (0.37) KDM4EALDH1A1NPC1RAB9AGLA
SCHEMBL2457805 0.77 KDM4E (0.47) KDM4EALDH1A1NPC1RAB9AGLA
SCHEMBL2457803 0.77 KDM4E (0.47) KDM4EALDH1A1NPC1RAB9AGLA
SCHEMBL28582151 0.77 KMT2A (0.36) ALDH1A1SMN1; SMN2MAPTNFKB1CYP1A2
SCHEMBL11597308 0.76 GRM4 (0.42) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL11597305 0.76 GRM4 (0.42) KDM4EALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL23367993 0.75 KMT2A (0.35) ALDH1A1MAPTNFKB1CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL28475833 0.75 TLR8 (0.36) ALDH1A1SMN1; SMN2MAPTNFKB1CYP1A2
Bromide SCHEMBL28409162 0.75 KMT2A (0.35) ALDH1A1MAPTNFKB1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349839-B1 PHENYLETHENYL OR PHENYLETHINYL DERIVATIVES AS GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2005-02-09 EP claimed